Zalicus' Series B Round

Zalicus raised a round of funding on September 23, 2002.

Zalicus, formerly CombinatoRx, is a biopharmaceutical company focused on developing new medicines built from synergistic combinations of approved drugs, designed to attack disease on multiple fronts. …

Articles about Zalicus' Series B Round: